Key facts
- This page summarizes J. Grayson Sanders's Form 4 filing for Griffin-American Healthcare REIT III, Inc..
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 01 Oct 2021, 20:56.
J. Grayson Sanders - 01 Oct 2021 Form 4 Insider Report for Griffin-American Healthcare REIT III, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 01 Oct 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Oct 2021, 20:56:09 UTC
- Prior SEC filing
- 16 Jun 2021
- Next SEC filing
- 22 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ J. GRAYSON SANDERS
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
J. Grayson Sanders filed Form 4 for Griffin-American Healthcare REIT III, Inc. on 01 Oct 2021.
Change
- Previous filing in this sequence was filed on 16 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
No ticker
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -18,342
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 01 Oct 2021
- Ownership
- Direct
- Footnotes
- F1
No ticker
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -27,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 01 Oct 2021
- Ownership
- By Sanders Living Trust DTD 1/25/2017
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
J. Grayson Sanders is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
Reflects the disposition of shares of the Issuer's common stock in connection with the merger (the "Merger") of the Issuer with and into Continental Merger Sub, LLC, a wholly-owned subsidiary of American Healthcare REIT, Inc. ("AHR"). In the Merger, each share of the Issuer's common stock, par value $0.01 per share, was converted into the right to receive 0.9266 shares of AHR Class I common stock, par value $0.01 per share ("AHR Class I Common Stock"). There is no established market for shares of AHR Class I Common Stock. On March 18, 2021, the board of directors of AHR approved an estimated value per share of AHR Class I Common Stock of $9.22.
Footnote F2
The reported shares of common stock are held directly by Sanders Living Trust, DTD 1/25/2017, and indirectly by J. Grayson Sanders and Marylee Sanders, Trustees.